Abstract
Purpose: We aimed to evaluate the diagnostic performance of the IMMULITE 2000 Allergy System from Diagnostic Products Corporation (DPC) for the detection of inhalant and food allergies, focusing on inhalant and food screens, mixes and single allergens.
Methods: Serum samples were collected from new, unselected patients who were referred to the allergist for a suspected allergy. Patients were classified as study diagnosis-positive for inhalant (food) allergy if they had both a positive clinical examination/history and a positive skin test for inhalant (food) allergy; otherwise – failing one or both of these criteria – they were classified as study diagnosis-negative. Classification and testing of the serum samples was carried out in a blinded fashion. Values greater than 0.35 kU/L were considered positive.
Results: Of the 118 patients included, 63 were considered study diagnosis-positive for inhalation and/or food allergy. DPC inhalation screening showed 82% total agreement (TA) and 91% sensitivity relative to the study diagnoses. The DPC food panel showed 96% TA and 98% specificity relative to the study diagnoses. Relative to specific intracutaneous testing (ICT), the DPC D1, E1 and E5 assays had sensitivity of 82–90%; tree and grass panels had sensitivity of 74% and 95%. The DPC weed panel and initial lots of DPC E5 had poor sensitivity (<40%); mold panel sensitivity was equally low for both DPC and the routinely used Pharmacia assay (36%). Relative to skin prick testing (SPT), specific food allergens had TA of 94–98% and specificity of 95–100%.
Conclusion: In patients classified by the combination of clinical examination/history and skin test results, the DPC IMMULITE 2000 Allergy System generally demonstrated acceptable sensitivity, specificity and TA compared to the study diagnoses, both at the screening level and at the level of panels and single allergens.
References
1. Dolen WK. Skin testing and immunoassays for allergen-specific IgE. Clin Rev Allergy Immunol 2001; 21: 229–39. 10.1385/CRIAI:21:2-3:229Search in Google Scholar
2. European Academy of Allergy and Clinical Immunology (EAACI), Section on Pediatrics: Høst A, Andrae S, Charkin S, et al. Allergy testing in children: why, who, when and how? Allergy 2003;58:559–69. 10.1034/j.1398-9995.2003.00238.xSearch in Google Scholar
3. Dolen WK. IgE antibody in the serum – detection and diagnostic significance. Allergy 2003; 58: 717–23. 10.1034/j.1398-9995.2003.00281.xSearch in Google Scholar
4. Hamilton RG, Adkinson NF Jr. Clinical laboratory assessment of IgE-dependent hypersensitivity. J Allergy Clin Immunol 2003; 111(Suppl 2): S687–701. 10.1067/mai.2003.123Search in Google Scholar
5. Plebani M, Bernardi D, Basso D, Borghesan F, Faggian D. Measurement of specific immunoglobulin E: intermethod comparison and standardization. Clin Chem 1998; 44: 1974–9. 10.1093/clinchem/44.9.1974Search in Google Scholar
6. Homburger HA. Diagnostic allergy testing; some new answers to old questions. Clin Lab News 2004; 30: 12–14 (online at www.aacc.org/cln/series/allergytest.pdf). Search in Google Scholar
7. Plebani M. Clinical value and measurement of specific IgE [review]. Clin Biochem 2003; 36: 453–69. 10.1016/S0009-9120(03)00037-7Search in Google Scholar
8. Paganelli R, Ansotegui IJ, Sastre J, Lange CE, Roovers MH, de Groot H, et al. Specific IgE antibodies in the diagnosis of atopic disease. Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy 1998; 53: 763–8. 10.1111/j.1398-9995.1998.tb03972.xSearch in Google Scholar
9. Yunginger JW, Ahlstedt S, Eggleston PA, Homburger HA, Nelson HS, Ownby DR, et al. Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol 2000; 105: 1077–84. 10.1067/mai.2000.107041Search in Google Scholar
10. Williams PB, Siegel C, Portnoy J. Efficacy of a single diagnostic test for sensitization to common inhalant allergens. Ann Allergy Asthma Immunol 2001; 86: 196–202. 10.1016/S1081-1206(10)62691-9Search in Google Scholar
11. Li TM, Chuang T, Tse S, Hovanec-Burns D, El Shami AS. Development and validation of a third generation allergen-specific IgE assay on the continuous random access IMMULITE 2000 analyzer. Ann Clin Lab Sci 2004; 34: 67–74. Search in Google Scholar
12. Guilloux L, Hamberger C. Évaluation du dosage des IgE spécifiques sur l'IMMULITE 2000 DPC. Immuno-Anal Biol Spécialisée 2004; 19: 71–80 (online at www.sciencedirect.com). 10.1016/j.immbio.2003.11.004Search in Google Scholar
13. Niemeijer NR. Skin test reagents in the diagnosis of atopic disease, PhD thesis. Delfzijl, The Netherlands: Drukkerij de Vries, 1996. Search in Google Scholar
14. Turkeltaub PC, Rastogi SC, Baer H, Anderson MC, Norman PS. A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. J Allergy Clin Immunol 1982; 70: 343–52. 10.1016/0091-6749(82)90023-9Search in Google Scholar
15. Proceedings of the Task Force on Guidelines for Standardizing Old and New Technologies Used for the Diagnosis and Treatment of Allergic Diseases. Washington, DC, June 18–19, 1987. J Allergy Clin Immunol 1988;82:487–526. 10.1016/0091-6749(88)90958-XSearch in Google Scholar
16. Dreborg S, editor. Skin tests used in type I allergy testing. Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989; 44(Suppl 10): 1–59. Search in Google Scholar
17. Newcombe RG, Altman DG. Proportions and their differences. In: Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with confidence: confidence intervals and statistical guidelines, 2nd ed. London, UK: BMJ Books 2000:45–56. Search in Google Scholar
18. NCCLS I/LA20-A. Evaluation of methods and analytical performance characteristics of immunological assays for human immunoglobulin E (IgE) antibodies of defined allergen specificities, approved guideline. NCCLS I/LA20-A Vol. 17, No. 24, 1997. Search in Google Scholar
19. Williams PB, Dolen WK, Koepke JW, Selner JC. Comparison of skin testing and three in vitro assays for specific IgE in the clinical evaluation of immediate hypersensitivity. Ann Allergy 1992; 68: 35–45. Search in Google Scholar
20. Ownby DR, Magera B, Williams PB. A blinded, multi-center evaluation of two commercial in vitro tests for latex-specific antibodies. Ann Allergy Asthma Immunol 2000; 84: 193–6. 10.1016/S1081-1206(10)62755-XSearch in Google Scholar
21. Nilsby I. Allergy to molds in Sweden. Acta Allergol 1949; 2: 57–90. 10.1111/j.1398-9995.1949.tb03281.xSearch in Google Scholar
22. Karlsson-Borga A, Jonsson P, Rolfsen W. Specific IgE antibodies to 16 widespread mold genera in patients with suspected mold allergy. Ann Allergy 1989; 63: 521–6. Search in Google Scholar
23. Kauffman HF, van der Heide S, Lange H, de Vries K. Antigenic and allergenic properties of Botrytis cinerea. In: Abstracts of the XIIth Congress of the European Academy of Allergology and Clinical Immunology, Budapest, 1986;1(Wo-11):75. Search in Google Scholar
©2005 by Walter de Gruyter Berlin New York
